{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:23:13Z","timestamp":1783077793875,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00105-026-05709-y","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:48:07Z","timestamp":1779889687000},"page":"448-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Wenn die Ursache verborgen bleibt: aktueller Stand zum chronischen Pruritus unklarer Genese","When the etiology remains unclear: status quo of chronic pruritus of unknown origin"],"prefix":"10.1007","volume":"77","author":[{"given":"Manuel P.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"5709_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2340\/00015555-0305","volume":"87","author":"S St\u00e4nder","year":"2007","unstructured":"St\u00e4nder\u00a0S et\u00a0al (2007) Clinical classification of itch: a\u00a0position paper of the International Forum for the Study of Itch. Acta Derm Venereol 87:291\u2013294","journal-title":"Acta Derm Venereol"},{"key":"5709_CR2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jaad.2019.06.038","volume":"81","author":"BS Kim","year":"2019","unstructured":"Kim\u00a0BS et\u00a0al (2019) Chronic pruritus of unknown origin (CPUO): Uniform nomenclature and diagnosis as a pathway to standardized understanding and treatment. J\u00a0Am Acad Dermatol 81:1223\u20131224","journal-title":"J Am Acad Dermatol"},{"key":"5709_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2340\/00015555-1949","volume":"95","author":"S St\u00e4nder","year":"2015","unstructured":"St\u00e4nder\u00a0S et\u00a0al (2015) Facing the challenges of chronic pruritus: a report from a multi-disciplinary medical itch centre in Germany. Acta Derm Venereol 95:266\u2013271","journal-title":"Acta Derm Venereol"},{"key":"5709_CR4","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2340\/00015555-1572","volume":"93","author":"U Matterne","year":"2013","unstructured":"Matterne\u00a0U et\u00a0al (2013) Incidence and determinants of chronic pruritus: a population-based cohort study. Acta Derm Venereol 93:532\u2013537","journal-title":"Acta Derm Venereol"},{"key":"5709_CR5","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3892","volume":"101","author":"MP Pereira","year":"2021","unstructured":"Pereira\u00a0MP et\u00a0al (2021) Chronic Pruritus of Unknown Origin: Clinical Profile and Disease-Related Burden. Acta Derm Venereol 101:adv00550","journal-title":"Acta Derm Venereol"},{"key":"5709_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2274291","volume":"34","author":"TA Kouwenhoven","year":"2023","unstructured":"Kouwenhoven\u00a0TA et\u00a0al (2023) Gabapentin and oral antidepressants for chronic pruritus: a prospective cohort study evaluating efficacy and side effects in daily dermatological practice. J\u00a0Dermatolog Treat 34:2274291","journal-title":"J Dermatolog Treat"},{"key":"5709_CR7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1097\/DAD.0000000000001902","volume":"43","author":"C Dehner","year":"2021","unstructured":"Dehner\u00a0C et\u00a0al (2021) Chronic Itch of Unknown Origin Is Associated With an Enhanced Th2 Skin Immune Profile. Am J Dermatopathol 43:773\u2013775","journal-title":"Am J Dermatopathol"},{"key":"5709_CR8","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1016\/j.jaip.2021.01.034","volume":"9","author":"YS Roh","year":"2021","unstructured":"Roh\u00a0YS et\u00a0al (2021) Circulating blood eosinophils as a biomarker for variable clinical presentation and therapeutic response in patients with chronic pruritus of unknown origin. J\u00a0Allergy Clin Immunol Pract 9:2513\u20132516","journal-title":"J Allergy Clin Immunol Pract"},{"key":"5709_CR9","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.jaad.2025.01.031","volume":"92","author":"J Manjunath","year":"2025","unstructured":"Manjunath\u00a0J et\u00a0al (2025) Comprehensive plasma cytokine profiling reveals a\u00a0distinct endotype of type\u00a02 inflammation in chronic pruritus of unknown origin. J\u00a0Am Acad Dermatol 92:1365\u20131367","journal-title":"J Am Acad Dermatol"},{"key":"5709_CR10","doi-asserted-by":"publisher","DOI":"10.1177\/1177271920940712","volume":"15","author":"K Salao","year":"2020","unstructured":"Salao\u00a0K et\u00a0al (2020) Interleukin-31 and Chronic Pruritus of Unknown Origin. Biomark Insights 15:1177271920940712","journal-title":"Biomark Insights"},{"key":"5709_CR11","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jaad.2025.08.006","volume":"93","author":"YM Akiska","year":"2025","unstructured":"Akiska\u00a0YM et\u00a0al (2025) Systemic immune profiling identifies elevated mas-related G\u2011coupled receptor membrane X2 (MRGPRX2) with a distinct inflammatory signature in chronic pruritus of unknown origin. J\u00a0Am Acad Dermatol 93:1566\u20131568","journal-title":"J Am Acad Dermatol"},{"key":"5709_CR12","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jaad.2023.06.045","volume":"89","author":"MZ Joel","year":"2023","unstructured":"Joel\u00a0MZ et\u00a0al (2023) Prevalence and comorbidity burden of prurigo nodularis in United States adults enrolled in the All of Us research program. J\u00a0Am Acad Dermatol 89:1056\u20131058","journal-title":"J Am Acad Dermatol"},{"key":"5709_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1265148","volume":"10","author":"SYD Lim","year":"2023","unstructured":"Lim\u00a0SYD et\u00a0al (2023) In vivo imaging of patients with chronic pruritus of unknown origin reveals partial sweat duct obstruction with partial itch resolution upon retinoid treatment. Front Med (Lausanne) 10:1265148","journal-title":"Front Med (Lausanne)"},{"key":"5709_CR14","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1111\/ddg.14830","volume":"20","author":"S St\u00e4nder","year":"2022","unstructured":"St\u00e4nder\u00a0S et\u00a0al (2022) S2k guideline: Diagnosis and treatment of chronic pruritus. J\u00a0Dtsch Dermatol Ges 20:1387\u20131402","journal-title":"J Dtsch Dermatol Ges"},{"key":"5709_CR15","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2340\/00015555-1246","volume":"92","author":"NQ Phan","year":"2012","unstructured":"Phan\u00a0NQ et\u00a0al (2012) Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 92:502\u2013507","journal-title":"Acta Derm Venereol"},{"key":"5709_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.2340\/00015555-1544","volume":"93","author":"K Krause","year":"2013","unstructured":"Krause\u00a0K et\u00a0al (2013) German version of ItchyQoL: validation and initial clinical findings. Acta Derm Venereol 93:562\u2013568","journal-title":"Acta Derm Venereol"},{"key":"5709_CR17","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1111\/jdv.16151","volume":"34","author":"MP Pereira","year":"2020","unstructured":"Pereira\u00a0MP et\u00a0al (2020) Generalized chronic itch induced by small-fibre neuropathy: clinical profile and proposed diagnostic criteria. J\u00a0Eur Acad Dermatol Venereol 34:1795\u20131802","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5709_CR18","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v105.44220","volume":"105","author":"E Weisshaar","year":"2025","unstructured":"Weisshaar\u00a0E et\u00a0al (2025) European S2k Guideline on Chronic Pruritus. Acta Derm Venereol 105:adv44220","journal-title":"Acta Derm Venereol"},{"key":"5709_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/01.ASW.0000803256.62585.d5","volume":"35","author":"S Fisher","year":"2022","unstructured":"Fisher\u00a0S et\u00a0al (2022) Phototherapy for Generalized Pruritus of Unknown Origin: Single-Center Experience. Adv Skin Wound Care 35:109\u2013111","journal-title":"Adv Skin Wound Care"},{"key":"5709_CR20","volume":"1","author":"A Andrade","year":"2020","unstructured":"Andrade\u00a0A et\u00a0al (2020) Interventions for chronic pruritus of unknown origin. Cochrane Database Syst Rev 1:CD013128","journal-title":"Cochrane Database Syst Rev"},{"key":"5709_CR21","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1080\/09546634.2021.1880542","volume":"33","author":"J Jeon","year":"2022","unstructured":"Jeon\u00a0J et\u00a0al (2022) Treatment of patients with chronic pruritus of unknown origin with dupilumab. J\u00a0Dermatolog Treat 33:1754\u20131757","journal-title":"J Dermatolog Treat"},{"key":"5709_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jdcr.2021.10.030","volume":"19","author":"N Edmonds","year":"2022","unstructured":"Edmonds\u00a0N et\u00a0al (2022) Six cases of refractory pruritus and histologic dermal hypersensitivity reaction successfully treated with dupilumab. JAAD Case Rep 19:28\u201333","journal-title":"JAAD Case Rep"},{"key":"5709_CR23","volume":"6","author":"LL Zhai","year":"2019","unstructured":"Zhai\u00a0LL et\u00a0al (2019) Chronic Pruritus Responding to Dupilumab\u2011A Case Series. Medicines (Basel) 6:72","journal-title":"Medicines (Basel)"},{"key":"5709_CR24","doi-asserted-by":"publisher","first-page":"e561","DOI":"10.1111\/1346-8138.17679","volume":"52","author":"S Nakayama","year":"2025","unstructured":"Nakayama\u00a0S et\u00a0al (2025) Immediate and sustained efficacy of nemolizumab in chronic pruritus of unknown origin. J\u00a0Dermatol 52:e561\u2013e562","journal-title":"J Dermatol"},{"key":"5709_CR25","first-page":"40","volume":"18","author":"DR Dasilva","year":"2025","unstructured":"Dasilva\u00a0DR et\u00a0al (2025) Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series. J\u00a0Clin Aesthet Dermatol 18:40\u201346","journal-title":"J Clin Aesthet Dermatol"},{"key":"5709_CR26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jamadermatol.2024.1464","volume":"160","author":"SG Kwatra","year":"2024","unstructured":"Kwatra\u00a0SG et\u00a0al (2024) Efficacy and Safety of Abrocitinib in Prurigo Nodularis and Chronic Pruritus of Unknown Origin: A\u00a0Nonrandomized Controlled Trial. JAMA Dermatol 160:717\u2013724","journal-title":"JAMA Dermatol"},{"key":"5709_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jdcr.2021.06.028","volume":"15","author":"T Buttgereit","year":"2021","unstructured":"Buttgereit\u00a0T et\u00a0al (2021) Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab. JAAD Case Rep 15:36\u201338","journal-title":"JAAD Case Rep"},{"key":"5709_CR28","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1007\/s00403-023-02707-1","volume":"315","author":"K Sardana","year":"2023","unstructured":"Sardana\u00a0K et\u00a0al (2023) Use of tofacitinib in recalcitrant cases of chronic pruritus of unknown origin. Arch Dermatol Res 315:2955\u20132957","journal-title":"Arch Dermatol Res"},{"key":"5709_CR29","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1001\/jamadermatol.2019.2804","volume":"155","author":"F Wang","year":"2019","unstructured":"Wang\u00a0F et\u00a0al (2019) Treatment of Refractory Chronic Pruritus of Unknown Origin With Tofacitinib in Patients With Rheumatoid Arthritis. JAMA Dermatol 155:1426\u20131428","journal-title":"JAMA Dermatol"},{"key":"5709_CR30","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jaad.2018.02.030","volume":"78","author":"G Yosipovitch","year":"2018","unstructured":"Yosipovitch\u00a0G et\u00a0al (2018) Serlopitant for the treatment of chronic pruritus: Results of a randomized, multicenter, placebo-controlled phase 2 clinical trial. J\u00a0Am Acad Dermatol 78:882\u2013891","journal-title":"J Am Acad Dermatol"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-026-05709-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05709-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:34:27Z","timestamp":1783074867000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-026-05709-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5709"],"URL":"https:\/\/doi.org\/10.1007\/s00105-026-05709-y","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.P.\u00a0Pereira und M.\u00a0Metz geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}